The ASX 200 has taken another hit on Wednesday, with the share market dragged lower by global trade tensions and another round of volatility on Wall Street.
While that's rattled confidence, experienced investors know that market selloffs can often create the best opportunities — especially when high-quality companies get marked down for reasons that have little to do with their long-term outlook.
If you've got a long-term view, this could be a great time to go hunting for value. Here are three ASX 200 shares that analysts rate highly that I'd be happy to buy during this selloff and hold for the years ahead.
Aristocrat Leisure Ltd (ASX: ALL)
Aristocrat is arguably one of the ASX 200's most underappreciated global players. Known for its gaming machines, the company has expanded into digital and online gaming. With a strong pipeline of content, high-margin earnings, and growing recurring revenue, Aristocrat has more depth than many investors realise.
The market selloff has brought the stock back from its highs, but brokers remain bullish on the long-term outlook. With a solid balance sheet and expanding international presence, Aristocrat offers a compelling mix of value, growth, and global diversification.
Last week, Bell Potter put a buy rating and $83.00 price target on its shares.
Pro Medicus Ltd (ASX: PME)
Pro Medicus has become one of the ASX's most admired growth stories — and for good reason. The radiology imaging software provider boasts huge margins, long-term contracts with some of the world's biggest hospitals, and a rock-solid balance sheet with no debt.
While the recent tech pullback has hit its share price very hard, the underlying business hasn't missed a beat. Demand for high-end diagnostic imaging is only growing, and Pro Medicus is winning deals across the world. If you're after a proven compounder with global ambitions, this ASX 200 share is worth a serious look.
Goldman Sachs is very bullish and has a buy rating and $309.00 price target on its shares.
Xero Ltd (ASX: XRO)
Xero shares have pulled back during the market selloff, but the long-term growth thesis remains intact. The cloud-based accounting software provider continues to add new subscribers, increase revenue per user, and expand globally — particularly in the UK and North America.
The company is also getting serious about profitability, with margins improving and free cash flow heading in the right direction. After being caught up in the tech selloff, Xero is now trading at a very attractive valuation — and for investors looking for exposure to sticky SaaS revenue and small business digitisation, this could be an attractive entry point.
Goldman Sachs certainly does. It has a buy rating and $201.00 price target on the ASX 200 share.
